Skip to content

Healthcare Services Group HCSG Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture

Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC

Other financials

Income statement

See full
Revenue$462.8M+3.4%
Gross profit$75.8M+11.6%
Net income$26.1M+51.3%
EPS (diluted)$0.37+60.9%

Balance sheet

See full
Cash & equivalents$136.2M+112%
Total debt$14.7M-11.1%
Total equity$513.8M-0.1%
Total assets$814.8M-1.0%

Cash flow

See full
Operating cash flow$43.7M+59.0%
CapEx$1.4M-19.8%
Free cash flow$42.3M+64.3%

Valuation

See full
Market cap$1.62B+76.0%

Profitability

See full
Gross margin13.3%0.0pp
Net margin3.7%+1.3pp
FCF margin8.4%

Returns & leverage

See full
Return on equity13.2%+4.8pp
Debt / equity0.0×
Current ratio3.1×+0.2×

Where this comes from

Reported directly by Healthcare Services Group in its filing.

Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation.

The official record: Healthcare Services Group’s 10-Q, filed April 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Healthcare Services Group's shares issued, value, share-based payment arrangement, after forfeiture.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Healthcare Services Group's shares issued, value, share-based payment arrangement, after forfeiture?
Healthcare Services Group (HCSG) reported shares issued, value, share-based payment arrangement, after forfeiture of -$2.71M in Q1 2026.
How has Healthcare Services Group's shares issued, value, share-based payment arrangement, after forfeiture changed year-over-year?
Healthcare Services Group's shares issued, value, share-based payment arrangement, after forfeiture decreased by 55.6% year-over-year, from -$1.74M to -$2.71M.
What does shares issued, value, share-based payment arrangement, after forfeiture mean?
The total dollar value of equity issued to employees and directors as part of compensation arrangements. This metric helps investors assess the dilution impact and the cost of equity-based incentive plans.